Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

12 Health Care Stocks Moving In Wednesday's After-Market Session

Author: Benzinga Insights | March 06, 2024 05:31pm

Gainers

  • SCWorx (NASDAQ:WORX) stock increased by 60.8% to $2.75 during Wednesday's after-market session. The market value of their outstanding shares is at $3.3 million.
  • IO Biotech (NASDAQ:IOBT) stock increased by 11.44% to $1.85. The company's market cap stands at $121.8 million. As per the press release, Q4 earnings came out yesterday.
  • Artelo Biosciences (NASDAQ:ARTL) stock moved upwards by 8.11% to $1.6. The market value of their outstanding shares is at $5.1 million.
  • NextCure (NASDAQ:NXTC) shares increased by 8.01% to $1.82. The market value of their outstanding shares is at $50.7 million.
  • Atara Biotherapeutics (NASDAQ:ATRA) shares moved upwards by 7.47% to $0.75. The market value of their outstanding shares is at $76.4 million.
  • Telesis Bio (NASDAQ:TBIO) stock moved upwards by 4.99% to $0.51. The market value of their outstanding shares is at $15.4 million.

Losers

  • Nexalin Technology (NASDAQ:NXL) shares fell 14.4% to $0.45 during Wednesday's after-market session. The market value of their outstanding shares is at $3.2 million.
  • Avalo Therapeutics (NASDAQ:AVTX) shares decreased by 12.04% to $4.53. The market value of their outstanding shares is at $3.6 million.
  • HeartBeam (NASDAQ:BEAT) shares declined by 11.97% to $1.43. The market value of their outstanding shares is at $37.5 million.
  • Trxade Health (NASDAQ:MEDS) shares declined by 10.7% to $15.45. The market value of their outstanding shares is at $18.6 million.
  • Vicarious Surgical (NYSE:RBOT) stock declined by 9.34% to $0.31. The market value of their outstanding shares is at $54.7 million. As per the news, the Q4 earnings report came out 2 days ago.
  • Creative Medical Tech (NASDAQ:CELZ) stock fell 8.62% to $4.35. The market value of their outstanding shares is at $6.0 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ARTL ATRA AVTX BEAT CELZ IOBT MEDS NXL NXTC RBOT TBIO WORX


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist